Cargando…
17-DMAG对EGFR-TKI耐药的非小细胞肺癌细胞株A549和H1975作用的研究
BACKGROUND AND OBJECTIVE: In the clinical treatment of patients with non-small cell lung cancer (NSCLC), the primary and acquired resistance of epidermal growth factor receptor-tyrosine kinase inhibitor (EGFR-TKI) limits its clinical application, this need to explore new strategy or method to overco...
| Formato: | Online Artículo Texto |
|---|---|
| Lenguaje: | English |
| Publicado: |
中国肺癌杂志编辑部
2014
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6000355/ https://www.ncbi.nlm.nih.gov/pubmed/25404267 http://dx.doi.org/10.3779/j.issn.1009-3419.2014.11.02 |